IMCC Operating Margin from 2010 to 2024
| IMCC Stock | USD 0.46 0.01 2.13% |
Check Im Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Im Cannabis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 3.9 M or Total Revenue of 51.2 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.4. IMCC financial statements analysis is a perfect complement when working with Im Cannabis Valuation or Volatility modules.
IMCC | Operating Margin |
Latest Im Cannabis' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Im Cannabis Corp over the last few years. It is Im Cannabis' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Im Cannabis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.24) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
IMCC Operating Margin Regression Statistics
| Arithmetic Mean | 0.16 | |
| Geometric Mean | 0.53 | |
| Coefficient Of Variation | 354.85 | |
| Mean Deviation | 0.52 | |
| Median | 0.59 | |
| Standard Deviation | 0.56 | |
| Sample Variance | 0.32 | |
| Range | 1.3253 | |
| R-Value | (0.78) | |
| Mean Square Error | 0.13 | |
| R-Squared | 0.61 | |
| Significance | 0.0006 | |
| Slope | (0.1) | |
| Total Sum of Squares | 4.46 |
IMCC Operating Margin History
About Im Cannabis Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Im Cannabis income statement, its balance sheet, and the statement of cash flows. Im Cannabis investors use historical funamental indicators, such as Im Cannabis's Operating Margin, to determine how well the company is positioned to perform in the future. Although Im Cannabis investors may use each financial statement separately, they are all related. The changes in Im Cannabis's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Im Cannabis's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Im Cannabis Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Im Cannabis. Please read more on our technical analysis and fundamental analysis pages.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in IMCC Stock
When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:Check out the analysis of Im Cannabis Correlation against competitors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share 3.623 | Quarterly Revenue Growth (0.04) | Return On Assets (0.15) | Return On Equity (0.94) |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.